Galera Therapeutics
(OTC) GRTX
Galera Therapeutics Financials at a Glance
Market Cap
$3.41M
Revenue (TTM)
$0.00
Net Income (TTM)
$149.05M
EPS (TTM)
$-0.13
P/E Ratio
-0.35
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$0.05
Volume
17,131
Open
$0.05
Price
$0.05
Volume
17,131
Open
$0.05
Previous Close
$0.05
Daily Range
$0.05 - $0.05
52-Week Range
$0.02 - $0.06
Dividend
$0.00
Beta (Volatility)
0.43 (Low)
Price
$0.05
Volume
17,131
Open
$0.05
Previous Close
$0.05
Daily Range
$0.05 - $0.05
52-Week Range
$0.02 - $0.06
GRTX News
GRTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Galera Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
3
CEO
John Mel Sorensen, MD
Website
www.galeratx.comHeadquarters
Malvern, PA 19355, US
GRTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-39%
Return on Assets
21%
Earnings Yield
-2.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.41M
Shares Outstanding
75.58M
Volume
17.13K
Short Interest
0.00%
Avg. Volume
55.31K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$2.54M
EBITDA
$2.54M
Operating Cash Flow
$0.00
Capital Expenditure
$0.00
Free Cash Flow
$0.00
Cash & ST Invst.
$6.38M
Total Debt
$0.00
Galera Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$3.41M
N/A
Market Cap/Employee
$1.14M
N/A
Employees
3
N/A
Net Income
$153.10M
+3204.9%
EBITDA
$1.94M
+138.4%
Quarterly Fundamentals
Net Cash
$6.38M
+104.5%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
20.71%
N/A
Return on Invested Capital
-38.80%
N/A
Free Cash Flow
$2.24M
+4.3%
Operating Cash Flow
$2.24M
+4.3%